Member Info for doze

Another problem is the dilution we have suffered means the whole investment can safely be ignored- as far as I am concerned anyway.

has not done any favours for this one- the Foreign Policy should not damage Georgia however, and if Russia is given an easier time of it BGEO should benefit

cleverclogs

I got the same feeling due to the start today as I was expecting another move up. Has someone lent out their shares then or is it a sell off?

Seems like a good buyback at the moment. Looks like there is nothing to worry about here.

Cheer up, Scott is bound to cutivate links with a certain businessman who talks the same language.

If they gap down then you get sold at a lower price because it has gone through your order level. I have a limit sell on a couple of stock but no stop loss which I execute manually. You could do a limit buy at the price you sold minus 2p to cover the spread then you would get your holding back at no loss if you wanted. I think you said you had 2,000 stock so a good amount to practice with! Sorry you have lost your stake as we may have lost a very interested, longstanding poster.

and Putin good for Xenetic

The world won't stop CM, stocks should bounce back quick enough

It's nice to know some investigation into the drop is going on. Can GBG find the Tesco robbers please, then we might go up.

I ticked you up there

new CEO in April maybe has caused this. after all he has defected from a competitor with deep pockets and maybe a worried mindset!

As skipper in a rough sea CM, you are very reassuring.

comments on GBG today at Stockopedia concluding drop in sp due to overdone valuation not allowing for disappointing rns'.

As you have industry knowledge I would be grateful if you could say whether Equiniti is a threat to GBG- poaching business/more operational gearing to undercut I have been here some time and it is turning into a disappointment. I am surprised you made no comment on Laws leaving, I have assumed in my posting that he is happy with the state of affairs but would like to hear some others back up my opinion. I am hoping GBG are more deep knowledge than Equiniti who concentrate on financial matters. GBG are more into identification verification lending itself to police/immigration work at a guess and so has to work in a quieter manner.

I like that last sentence and recent announcement of research with IME to promote global water solutions underlines the ambitions here. DeSouza has a 26.76% holding and those 'due diligence' Amati vct holders are a good confidence vote. I bought in today and am looking forward to a dividend from this low capital/high utility oriented company.

1. Recommended Dividend for the period of 18 months ended on 30th June, 2016 : 5% final cash dividend i.e. Taka 0.50 per share, in addition to 10% interim cash and 5% stock dividend recommended by the Board of Directors of the Company on April 20, 2016 having record date as May 12, 2016. With 10% interim cash dividend already paid, the cumulative dividend for the period amounts to 15% cash and 5% stock. 2. Record date : The Record date for entitlement of 5% final cash dividend will be November 1, 2016. The Shareholders whose names appear in the Share Register of the Company or in the Depository Register on the record date i.e. November 1, 2016 will be entitled to receive the 5% final cash dividend. 5% stock dividend will be entitled by the shareholders whose names appeared in the Share Register of the Company or in the Depository Register on the earlier declared record date i.e. May 12, 2016. ......... I misled with last post

I like this bit in the rns.......... Sotalol was fully developed in-house and this approval demonstrates our continued focus on strengthening capabilities, especially our competitive R&D and regulatory skills. Looks like BXP is on a good trend. The cash div is only .5p or less but the stock div is 5%.

Issuer Xenetic Biosciences, Inc. Units offered 500,000 units, consisting of one share of convertible Series B Preferred Stock and a Class A Warrant to purchase one share of common stock, and 2,000,000 units, consisting of one share of convertible Series B Preferred Stock and a Class B Warrant to purchase one share of common stock. This prospectus also relates to the offering of the shares of common stock issuable upon conversion of the Series B Preferred Stock and upon exercise of the Class A and Class B Warrants. The Class A Warrants will be issued to existing institutional investors of our common stock. All other investors will receive Class B Warrants. http://ir.xeneticbio.com/all-sec-filings#document-1914-0001683168-16-000354

Chris Clark will not take over from Richard Law until 1/4/17 so he is retiring on amicable terms and wants to see the best for the business going forward- just in case of any doubt I thought I would say this.